The expanding therapeutic armamentarium available for inflammatory bowel disease (IBD)
as well as multiple compounds in clinical development inevitably raises questions as to their …

There are six important trends that will impact the future of inflammatory bowel disease
therapy.(1) Increased use of the biomarkers C-reactive protein (CRP) and fecal calprotectin …

New targets in inflammatory bowel disease therapy: 2021 : Current Opinion in
Gastroenterology New targets in inflammatory bowel disease therapy: 2021 : Current …

The use of combination therapy with a biologic agent and immunosuppressant has well-
established efficacy and safety and is common practice in the management of inflammatory …

The current goal of inflammatory bowel disease (IBD) treatment is a symptom-free everyday
life accompanied by mucosal healing with minimal use of corticosteroids. Recent therapeutic …

The mechanisms underlying the chronic intestinal inflammation that is a hallmark of
inflammatory bowel diseases (IBD) are complex. Components of the pathological response …

The first possibility is a precision medicine-like, biomarker-based approach as in oncology.
Availability of validated drug-specific or agnostic biomarkers targeting patients likely to …

Although the therapeutic armamentarium of Inflammatory bowel diseases (IBD) physicians
has expanded rapidly in recent years, a proportion of patients remain with a suboptimal …

Outcomes for patients starting a new treatment for inflammatory bowel disease are
characterized by uncertainty of treatment response. Although it is natural to hope that new …

Crohn's disease (CD) and ulcerative colitis (UC), known as inflammatory bowel diseases
(IBD), are characterized by chronic inflammation of the gastrointestinal tract. Over the last …